Safety and efficacy of the combination of ibrutinib and nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukemia Meeting Abstract


Authors: Younes, A.; Brody, J.; Carpio, C.; Lopez-Guillermo, A.; Ben-Yehuda, D.; Ferhanoglu, A. B.; Nagler, A.; Ozcan, M.; Avivi, I.; Albareda, F. B.; Barrigón, M. D. C.; Masood, A.; Streit, M.; Alvarez, J.; Ceulemans, R.; Masouleh, B. K.; Balasubramanian, S.; Schaffer, M.; Wang, S. S.; Fourneau, N.; Jurczak, W.
Abstract Title: Safety and efficacy of the combination of ibrutinib and nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukemia
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419402083
PROVIDER: wos
DOI: 10.1182/blood.V130.Suppl_1.833.833
Notes: Meeting Abstract: 833 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anas Younes
    319 Younes